Clinical Trials Directory

Trials / Completed

CompletedNCT01594294

An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues

EVALUATION OF THE EFFECTS OF CLEAR CARE® / AOSEPT® PLUS HYDROGEN PEROXIDE SOLUTION ON THE EYELID TISSUES - Part III: COMPARATIVE EVALUATION WITH RENU® MPS OVER 3 MONTH OF WEAR - CONTROL EVALUATION WITH AIR OPTIX® AQUA and ACUVUE® 2®

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to assess and compare the effect of the repeated usage of 2 different care systems (one hydrogen peroxide based cleaning and disinfecting system and one PHMB containing multipurpose system) with ACUVUE® 2® and AIR OPTIX® AQUA contact lenses worn on a daily wear basis for a 3-month period.

Detailed description

This study was divided into 2 periods, a Screening Phase and an Investigational Phase. During the Screening Phase, subjects were fitted and dispensed with either ACUVUE® 2® (for current hydrogel wearers) or AIR OPTIX® AQUA (for current silicone hydrogel wearers) contact lenses and used COMPLETE® MPS Easy Rub® Formula to clean and disinfect their lenses. At the completion of the Screening Phase, the symptomatic status of the subjects was re-assessed. Those subjects who qualified proceeded to the Investigational Phase and were dispensed with new pair of study contact lenses identical to the lenses they wore during the Screening Phase to use in conjunction with the allocated study care product, CLEAR CARE® /AOSEPT® Plus or ReNu MultiPlus®.

Conditions

Interventions

TypeNameDescription
DEVICEAOSEPT® Plus contact lens solutionHydrogen peroxide-based cleaning and disinfection system
DEVICEReNu MultiPlus® contact lens solutionPolyaminopropyl biguanide (PHMB) preserved multipurpose solution
DEVICEEtafilcon A contact lensesHydrogel contact lenses worn on a daily wear basis for 14 days (Screening Phase) and 3 months (Investigational Phase). During the Investigational Phase, the contact lenses lenses were worn a minimum of six hours per day, 5 days per week, with a fresh pair dispensed every 2 weeks.
DEVICELotrafilcon B contact lensesSilicone hydrogel contact lenses worn on a daily wear basis for 30 days (Screening Phase) and 3 months (Investigational Phase). During the Investigational Phase, the contact lenses lenses were worn a minimum of six hours per day, 5 days per week, with a fresh pair dispensed monthly.
DEVICECOMPLETE® MPS Easy Rub® Formula contact lens solutionPHMB 0.0001% and poloxamer 0.05% multipurpose solution

Timeline

Start date
2012-04-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2012-05-09
Last updated
2014-07-25
Results posted
2014-07-25

Source: ClinicalTrials.gov record NCT01594294. Inclusion in this directory is not an endorsement.